The metabolic vicious cycle in heart failure

[1]  G. Rosano,et al.  Trimetazidine improves left ventricular function and quality of life in elderly patients with coronary artery disease , 2004 .

[2]  M. Chandler,et al.  Malonyl Coenzyme A Decarboxylase Inhibition Protects the Ischemic Heart by Inhibiting Fatty Acid Oxidation and Stimulating Glucose Oxidation , 2004, Circulation research.

[3]  R. Shannon,et al.  Effects of Glucagon-Like Peptide-1 in Patients With Acute Myocardial Infarction and Left Ventricular Dysfunction After Successful Reperfusion , 2004, Circulation.

[4]  M. Bristow.  Etomoxir: a new approach to treatment of chronic heart failure , 2000, The Lancet.

[5]  E. Fallen,et al.  The Effects of β1-Blockade on Oxidative Metabolism and the Metabolic Cost of Ventricular Work in Patients With Left Ventricular Dysfunction , 2000 .

[6]  J. Mccormack,et al.  Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions Potential for pharmacological interventions , 1997 .

[7]  G. Radda,et al.  Is a high glycogen content beneficial or detrimental to the ischemic rat heart? A controversy resolved. , 1996, Circulation research.

[8]  R. Bersin,et al.  Improved hemodynamic function and mechanical efficiency in congestive heart failure with sodium dichloroacetate. , 1994, Journal of the American College of Cardiology.

[9]  L. Opie,et al.  Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias , 1994, The Lancet.

[10]  E. Newsholme,et al.  The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. , 1963, Lancet.

[11]  L. Opie,et al.  Fatty Acid and Glucose Metabolism in the Perfused Heart , 1961, Nature.